Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name LINC00668
   Synonyms NA
   Region GRCh38_18:6919496-6929966    Sequence
   Ensembl ENSG00000265933
   RefSeq NR_034100
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name oral squamous cell carcinoma
   ICD-0-3 C06.9  M8070/3
   Methods RNAi, Western blot, qPCR, Luciferase reporter assays, RNA pull-down assays
   Sample OSCC tissues, cell lines (SCC4, SCC9, SCC1, SCC25, TU183, HSU3, FADU, OEC-M1, SNU1041, and SCC15)
   Expression Pattern up-regulated
   Function Description

LINC00668 is up-regulated in human primary OSCC tissues.We first demonstrated that LINC00668 expression was up-regulated, which was correlated with tumor progression, and miR-297 down-regulated in OSCC tissues and cells. Importantly, LINC00668 expression was negatively correlated with miR-297 expression in OSCC tissues. Loss-of-function of LINC00668 revealed that LINC00668 functioned as a ceRNA for miR-297 to facilitate VEGFA expression, promoting OSCC progression. Finally, we confirmed that LINC00668 promoted OSCC activity through VEGFA signaling.In conclusion, these results suggest that LINC00668 promotes OSCC tumorigenesis via miR-297/VEGFA axis, which may provide a new target for the diagnosis and therapy of OSCC disease.

   Pubmed ID 28564590
   Year 2017
   Title Long intergenic non-coding RNA 668 regulates VEGFA signaling through inhibition of miR-297 in oral squamous cell carcinoma.
   External Links
   Links for  LINC00668 GenBank       HGNC       lncrnadb       Noncode
   Links for  oral squamous cell carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.